I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!
I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!
And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic
Savvy Updates, 5/8/23: CGM Disruptions (Dexcom & Abbott), Japanese Diet & NAFLD, UPFs & Brain Health, Weight Loss Drug $$, Envision Bankruptcy
Most adults with diabetes report CGM disruptions due to device problems, medical care by Alexis McKee for Healio.com/endocrinology, 3 May 2024. More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of...
Savvy D Living, 5/3/23: TCOYD on Carbs, Digestive Organs Vary, T1D in Hospital, T1D and Teeth, Burden of T1D Living, About Hair
TCOYD: All about Carb Counting with Drs. Steve Edelman and Jeremy Pettus These are 2 great videos (among many others) by TCOYD about carbs, carb counting and how to count fiber in your carb counting. I've always said that T1D would be WAY easier to manage if it...
Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023
Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023. Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Savvy on Glucagon, 4/19/23: With Tim Street on Glucagon and Microdosing
Glucagon me… n=1 experiments with microbolusing Glucagon by Tim Street for Diabettech.com, 4-5 April 2023. Part 1: Setting a Baseline Glucagon is a hormone that is produced by the alpha cells and is critical in maintaining glucose homeostasis. It works with the many...
Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?
Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023. ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
Savvy Updates 4/10/23: Abbott FreeStyle Libre Class 1 Recall, 2 T Cell Populations, Gut Health on TikTok, Pancreatic Endocrine & Exocrine Cells, “Counting Carbs is a Crapshoot!”
Abbott faces Class I recall of 4.2M glucose readers on battery fire risks by Peter Green for MedTechDive.com, 6 April 2023. Abbott has initiated a recall for readers for its FreeStyle Libre glucose monitoring systems, which are at risk of catching fire if improperly...
Savvy Health 4/5/23: Gut Microbiome in Infancy, Walnuts for Heart Health, Pscyhosocial Screen for Diabetes Distress, Plants Scream When Stressed
Gut microbiome during infancy may predict future type 1 diabetes by Michael Monostra for Healio.com/endocrinology, 27 March 2023. Children who develop type 1 diabetes may have biomarkers present in the gut microbiome as early as age 1 year, according to a...
Savvy Updates, 4/3/23: Glucose-run Fuel Cell to Power Insulin Release, Inreda Diabetic AP Coming to Market 2024, Biomea Fusion BMF-219 May Preserve Beta Cells, Bigfoot Biomedical Buys Insulin Titration Algorithm, Verapamil Preserves C-Peptide Levels, OOP Cost of Diabetes Medications, PBMs Under Scrutiny, Splenda® Stevia Farm
Scientists use implanted glucose-run fuel cell to power insulin release by Nick Paul Taylor for MedTechDive.com, 29 March 2023. There is a need for better ways to power medical implants. Devices either have a battery that gradually runs down and...
Savvy Update, 3/27/23: Non-Invasive Monitoring: Know Labs & Hagar’s GWave, California’s Brand of Insulin, Steatosis in Adult T1Ds, MDs Leaving Their Jobs, Colorectal Cancers in Adult T1Ds, Off-Label Prescribing
Know Labs establishes scientific advisory board to advance non-invasive glucose monitoring by Sean Whooley for DrugDeliveryBusiness.com, 22 March 2023. Know Labs announced that it established a scientific advisory board to accelerate the development of its glucose...
More Diabetes Blogs